The House Resolution introduced by Representatives Malagari and others recognizes June 2025 as "Scleroderma Awareness Month" and June 29, 2025, as "World Scleroderma Day" in Pennsylvania. Scleroderma is a rare autoimmune disease characterized by the hardening and tightening of the skin, which can also affect internal organs such as the heart, lungs, and gastrointestinal tract. Approximately 300,000 individuals in the U.S. are affected by scleroderma, with a significant portion being women and a higher prevalence among African Americans. The resolution highlights the importance of awareness regarding the symptoms, diagnosis, and treatment options for this condition, as well as the ongoing research efforts by institutions in Pennsylvania.

The resolution emphasizes that while there is currently no cure for scleroderma, various treatments can help manage symptoms and improve quality of life. It aims to raise awareness about the disease, encouraging individuals to learn more about its symptoms and the available support for those affected. By designating June as Scleroderma Awareness Month, the resolution seeks to foster greater understanding and support for individuals living with this rare disease.